Lyme Disease Antibody w/ Reflex to Blot (IgG, IgM)Main Content
Test Code: 6646
CPT Code(s): 86618
Includes: If Lyme Disease Antibody Screen is Equivocal or Positive, Lyme Disease Antibodies (IgG, IgM), Immunoblot will be performed at an additional charge (CPT code(s): 86617 x2).
Methodology: Immunoassay (IA)
Clinical Significance: Lyme disease is caused by a bacterium borrelia burgdorferi and is transmitted by ticks. EIA is the screening test with high sensitivity for antibody detection. Immunoblot testing qualitatively examines with high specificity antibodies in a patient's specimen. Immunoblot testing is appropriate for confirming a detected EIA test result.
Alternative Name(s): Borrelia burgdorferi, Lyme Screening, Lyme Antibody Screen
Supply: T01 - Red/Gray SST 8.5mL
Preferred Specimen: Serum
Preferred Volume: 1mL
Transport Container: Serum Separator Tube (SST)
Transport Temperature: Room Temperature
Specimen Stability: Room Temperature: 7 Days
Rejection Criteria: Gross hemolysis; Gross lipemia; Plasma
For additional supply or collection device information, please contact DLO's Customer Service at (800) 891-2917, option 2.
The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the Payor being billed.